Boston Scientific Vercise™ Deep Brain Stimulation System Receives CE Mark Approval For Treatment Of Dystonia

The Boston Scientific Corporation (NYSE:BSX) Vercise™ Deep Brain Stimulation (DBS) System has received CE Mark approval for the treatment of intractable primary and secondary dystonia, a neurological movement disorder characterized by involuntary muscle contractions.
Source: Medical Design Online News - Category: Medical Equipment Source Type: news